LifeStance Health (LFST) Common Equity (2020 - 2026)

LifeStance Health (LFST) has 7 years of Common Equity data on file, last reported at $1.5 billion in Q1 2026.

• Quarterly Common Equity rose 1.39% year-over-year to $1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 1.39% YoY) and the FY2025 annual result came in at $1.5 billion, up 5.17% from the prior year.
• Common Equity slipped to $1.5 billion in Q1 2026 per LFST's latest filing, from $1.5 billion in the prior quarter.
• Across five years, Common Equity topped out at $1.5 billion in Q1 2022 and bottomed at $1.4 billion in Q4 2023.
• The 5-year median for Common Equity is $1.5 billion (2026), against an average of $1.5 billion.
• The widest annual swing landed in 2022, when Common Equity surged 61.69%; it then decreased 5.91% in 2023.
• Tracing LFST's Common Equity over 5 years: stood at $1.5 billion in 2022, then fell by 5.91% to $1.4 billion in 2023, then grew by 1.21% to $1.4 billion in 2024, then grew by 5.17% to $1.5 billion in 2025, then slipped by 2.87% to $1.5 billion in 2026.
• Per Business Quant, the three latest LFST Common Equity figures stand at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025).

Peer Comparison